Form 4: IN8BIO Director Luba Greenwood Acquires Stock Options

IN8BIO, INC. reports that Director Luba Greenwood acquired 22,000 stock options with an exercise price of $1.58, vesting monthly starting June 9, 2026.

Summary

• Luba Greenwood, a Director at IN8BIO, Inc., has acquired 22,000 stock options.
• The options have an exercise price of $1.58 per share.
• Vesting will occur in equal monthly installments, with one-twelfth vesting each month starting June 9, 2026.
• The options will be fully vested by the company's next annual meeting of stockholders, provided Greenwood continues to provide services.
• The transaction was reported on May 12, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is typical compensation and not indicative of immediate positive or negative performance.

Positives

• Director Luba Greenwood's acquisition of stock options indicates a commitment to the company's future performance.
• The vesting schedule aligns with continued service, incentivizing long-term engagement.

Risks

• The value of the stock options is contingent on the future performance of IN8BIO, Inc.'s stock price.
• If the reporting person ceases to provide services, the vesting of options may be impacted.

Future Outlook

The stock options are exercisable and will vest over time, with full vesting anticipated by the company's next annual meeting of stockholders, subject to continued service.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology sector to align executive interests with shareholder value and incentivize long-term growth.

Stakeholder Impact

• Shareholders: The stock option grant aligns director incentives with long-term shareholder value creation.
• Employees: The vesting schedule may indirectly influence employee morale and retention if similar incentives are offered.

Next Steps

• Monthly vesting of stock options commencing June 9, 2026.
• Full vesting of stock options by the company's next annual meeting of stockholders, contingent on continued service.

Key Dates

Keywords

IN8BIO, INAB, Form 4, Stock Options, Director, Beneficial Ownership, Securities, Vesting Schedule